DNA Damage and Repair in Parkinsons Disease

帕金森病的 DNA 损伤与修复

基本信息

项目摘要

DESCRIPTION (provided by applicant): Neurons may be particularly prone to DNA damage by reactive oxygen species due to their high metabolic activity and low levels of antioxidant defenses [1]. Repair of oxidative DNA damage is therefore essential for normal brain function. Very little is known about neuronal DNA repair and therefore it is an important field for investigation. An etiological link to DNA damage via oxidative stress has been implicated in the pathogenesis of Parkinson's disease (PD) [2, 3]. PD is a progressive neurodegenerative disorder that is pathologically characterized largely by the loss of dopaminergic neurons of the substantia nigra. The initial underlying mechanism(s) that triggers neurodegeneration in PD is unknown. Elevated levels of DNA damage were detected in the dopaminergic neurons of the substantia nigra in PD patients [4-6]. It is unclear whether DNA damage is responsible for neuronal loss or is an epiphenomenon of the disease in the surviving neurons. Expression of "GO" enzymes (OGG1, MUTY, and MTH1), proteins involved in the repair of oxidative DNA damage, were also found to be increased in the dopaminergic neurons in the substantia nigra of PD patients [7- 9]. However, the extent to which the GO system acts to prevent DNA damage and/or mutations in both the nuclear and mitochondrial genomes in neurons is presently unclear. The proposed experiments will test the hypothesis that DNA damage is an early event in dopaminergic cell loss in the substantia nigra and that the GO pathway is important in protecting against such oxidative DNA damage. If DNA damage is potentially an underlying mechanism of neuronal degeneration, and GO repair is important in preventing this damage, these represent novel targets for the development of treatments to slow the progression of PD. A combination of molecular, biochemical and cellular techniques using rotenone models of PD and human postmortem brain tissues will be utilized. This proposal has the following two specific aims: (1) Determine the temporal and spatial role of DNA damage in the progressive loss of dopaminergic neurons; and (2) Determine the role of the GO members (OGG1, MutY, Mth1) in the repair of rotenone-induced DNA damage in both in vitro and in vivo models of PD.
描述(由申请人提供): 由于神经元的高代谢活性和低水平的抗氧化防御,神经元可能特别容易受到活性氧物种的DNA损伤[1]。因此,氧化DNA损伤的修复对于正常的大脑功能是必不可少的。由于对神经元DNA修复知之甚少,因此它是一个重要的研究领域。通过氧化应激导致DNA损伤的病因学联系被认为与帕金森氏病(PD)的发病机制有关[2,3]。帕金森病是一种进行性神经退行性疾病,其病理特征主要是黑质多巴胺能神经元的丢失。引发帕金森病神经变性的最初潜在机制(S)尚不清楚。帕金森病患者黑质多巴胺能神经元DNA损伤水平升高[4-6]。目前尚不清楚DNA损伤是否导致神经元丢失,或者是存活神经元中的一种附带现象。参与DNA氧化损伤修复的GO酶(OGG1、MUTY和MTH1)的表达也被发现在PD患者黑质中的多巴胺能神经元中增加[7-9]。然而,GO系统在多大程度上防止神经元核和线粒体基因组中的DNA损伤和/或突变目前尚不清楚。拟议的实验将检验这样一种假设,即DNA损伤是黑质多巴胺能细胞丢失的早期事件,GO途径在保护这种氧化DNA损伤方面起着重要作用。如果DNA损伤可能是神经元变性的潜在机制,而GO修复在防止这种损伤中是重要的,那么这些就是开发减缓PD进展的治疗方法的新靶点。使用鱼藤酮模型的PD和人类死后脑组织的分子、生化和细胞技术的组合将被利用。这项研究有两个具体目的:(1)确定DNA损伤在多巴胺能神经元进行性丢失中的时空作用;(2)在体外和体内PD模型中,确定GO成员(OGG1、MutY、MTH1)在修复鱼藤酮诱导的DNA损伤中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAURIE H SANDERS其他文献

LAURIE H SANDERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAURIE H SANDERS', 18)}}的其他基金

Mechanisms of mitochondrial genome integrity in familial and idiopathic Parkinson's disease
家族性和特发性帕金森病线粒体基因组完整性的机制
  • 批准号:
    10353124
  • 财政年份:
    2021
  • 资助金额:
    $ 0.96万
  • 项目类别:
Mechanisms of mitochondrial genome integrity in familial and idiopathic Parkinson's disease
家族性和特发性帕金森病线粒体基因组完整性的机制
  • 批准号:
    10533639
  • 财政年份:
    2020
  • 资助金额:
    $ 0.96万
  • 项目类别:
Mechanisms of mitochondrial genome integrity in familial and idiopathic Parkinson's disease
家族性和特发性帕金森病线粒体基因组完整性的机制
  • 批准号:
    10470384
  • 财政年份:
    2020
  • 资助金额:
    $ 0.96万
  • 项目类别:
Mechanisms of mitochondrial genome integrity in familial and idiopathic Parkinson's disease
家族性和特发性帕金森病线粒体基因组完整性的机制
  • 批准号:
    10098948
  • 财政年份:
    2020
  • 资助金额:
    $ 0.96万
  • 项目类别:
Mechanisms of mitochondrial genome integrity in familial and idiopathic Parkinson's disease
家族性和特发性帕金森病线粒体基因组完整性的机制
  • 批准号:
    10622266
  • 财政年份:
    2020
  • 资助金额:
    $ 0.96万
  • 项目类别:
Mechanisms of mitochondrial genome integrity in familial and idiopathic Parkinson's disease
家族性和特发性帕金森病线粒体基因组完整性的机制
  • 批准号:
    10266792
  • 财政年份:
    2020
  • 资助金额:
    $ 0.96万
  • 项目类别:
Mechanisms of mitochondrial genome integrity in familial and idiopathic Parkinson's disease
家族性和特发性帕金森病线粒体基因组完整性的机制
  • 批准号:
    10687197
  • 财政年份:
    2020
  • 资助金额:
    $ 0.96万
  • 项目类别:
Mechanisms of mitochondrial genome integrity in familial and idiopathic Parkinson's disease
家族性和特发性帕金森病线粒体基因组完整性的机制
  • 批准号:
    10914717
  • 财政年份:
    2020
  • 资助金额:
    $ 0.96万
  • 项目类别:
DNA Damage and Repair in Parkinsons Disease
帕金森病的 DNA 损伤与修复
  • 批准号:
    7905370
  • 财政年份:
    2010
  • 资助金额:
    $ 0.96万
  • 项目类别:

相似海外基金

Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
  • 批准号:
    24K18002
  • 财政年份:
    2024
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
  • 批准号:
    2222215
  • 财政年份:
    2023
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
  • 批准号:
    23K09272
  • 财政年份:
    2023
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
  • 批准号:
    10652764
  • 财政年份:
    2023
  • 资助金额:
    $ 0.96万
  • 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
  • 批准号:
    10730652
  • 财政年份:
    2023
  • 资助金额:
    $ 0.96万
  • 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
  • 批准号:
    22K11609
  • 财政年份:
    2022
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
  • 批准号:
    22K16720
  • 财政年份:
    2022
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
  • 批准号:
    RGPIN-2018-04107
  • 财政年份:
    2022
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
  • 批准号:
    RGPIN-2019-05674
  • 财政年份:
    2022
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
  • 批准号:
    22K12824
  • 财政年份:
    2022
  • 资助金额:
    $ 0.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了